Insiders / Doyle Mittie
Doyle Mittie
CIK 1918845personinsider
Companies
1
First seen
Mar 2, 2026
Last activity
Mar 18, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Avalo Therapeutics, Inc. · AVTX | 3,622 | — |
All securities held
2 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Avalo Therapeutics, Inc. | Common Stock | 3,622 |
| Avalo Therapeutics, Inc. | Stock Option (Right to Buy)Derivative | 149,008 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Sell | AVTX Avalo Therapeutics, Inc. Common Stock | $411.6K | -25K -87.56% | 3,622 <0.01% of shares | medium |
| Mar 16, 2026 | Exercise | AVTX Avalo Therapeutics, Inc. Common Stock | $246.7K | +20K +538.38% | 23,122 0.04% of shares | low |
| Mar 16, 2026 | Exercise | AVTX Avalo Therapeutics, Inc. Common Stock | $48.2K | +6K +25.91% | 29,114 0.05% of shares | low |
| Mar 16, 2026 | Exercise | AVTX Avalo Therapeutics, Inc. Stock Option (Right to Buy) | — | -6K -3.87% | 149,008 0.28% of shares | low |
| Mar 16, 2026 | Exercise | AVTX Avalo Therapeutics, Inc. Stock Option (Right to Buy) | — | -20K -8.33% | 214,500 0.40% of shares | low |
| Feb 26, 2026 | Grant | AVTX Avalo Therapeutics, Inc. Stock Option (Right to Buy) | — | +105K | 105,000 0.20% of shares | low |